A New Hope for Anemia in Chronic Kidney Disease (CKD)
Chronic Kidney Disease (CKD) affects millions of people worldwide, and one of its most common complications is anemia — a condition in which the body doesn’t produce enough red blood cells. This often happens because damaged kidneys make less erythropoietin (EPO) — a natural hormone that helps form red blood cells.
Low red blood cell levels can cause fatigue, weakness, shortness of breath, and reduced quality of life. For many patients, treating this anemia is an ongoing challenge, especially when standard therapies fail to bring lasting relief.
That’s where LuciVadadu comes in — a treatment designed with both innovation and care to help manage anemia more effectively.
What Is LuciVadadu?
LuciVadadu (Vadadustat tablets 150 mg) is an oral medication developed by Lucius Pharmaceuticals. It comes in a bottle containing 60 tablets.
LuciVadadu helps the body produce more red blood cells naturally, making it especially useful for adults with chronic kidney disease (CKD) who are not on dialysis.
The goal of LuciVadadu therapy is to maintain hemoglobin levels between 10 g/dL and 11 g/dL, helping patients feel more energetic and improving overall well-being.
How LuciVadadu Works
LuciVadadu contains Vadadustat, a medicine that supports your body’s ability to make red blood cells by gently activating its natural response to low oxygen. Here’s how it works:
- Blocks a Key Enzyme:
Vadadustat inhibits an enzyme called HIF-prolyl hydroxylase (HIF-PH). - Mimics Low Oxygen Conditions:
By blocking this enzyme, LuciVadadu helps stabilize hypoxia-inducible factor (HIF) — a natural protein that signals the body to respond as if oxygen levels are low. - Boosts Erythropoietin (EPO) Production:
Stabilized HIF increases the production of EPO, which stimulates the bone marrow to produce red blood cells. - Improves Iron Utilization:
HIF activation also enhances the way the body absorbs and uses iron — an important element for building healthy red blood cells. - Raises Hemoglobin Levels:
As a result, LuciVadadu helps increase red blood cell count and hemoglobin levels, improving energy and reducing the need for blood transfusions.
Why LuciVadadu Is Used
LuciVadadu is prescribed for:
- Treating anemia in adults with chronic kidney disease (CKD) who are not receiving dialysis.
- Supporting dialysis patients who have been on dialysis for at least three months.
- Reducing or eliminating the need for blood transfusions by stimulating natural red blood cell production.
A Trusted Innovation from Lucius Pharmaceuticals
At Lucius Pharmaceuticals, our goal is to make high-quality, effective, and affordable treatments accessible to patients around the world. LuciVadadu represents our ongoing commitment to improving the lives of people living with chronic conditions like CKD-related anemia — through science, compassion, and innovation.
Important Note
Always use LuciVadadu under the guidance of a qualified healthcare professional. Your doctor will determine the right dose and monitor your hemoglobin levels regularly to ensure safe and effective treatment.
